Anzeige
Mehr »
Sonntag, 07.09.2025 - Börsentäglich über 12.000 News
Tokenisierung entfesselt: Republic führt die Ethereum-Revolution
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0DLB7 | ISIN: CA88337V1004 | Ticker-Symbol: TTX
Frankfurt
05.09.25 | 08:05
0,103 Euro
-9,65 % -0,011
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
THERALASE TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
THERALASE TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1070,13306.09.

Aktuelle News zur THERALASE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiTheralase Technologies Inc: Theralase Technologies 1.84 million warrants extended2
DiTheralase Technologies is very undervalued, this analyst says1
30.08.Theralase Technologies Inc: Theralase to extend expiry of 1.84M warrants to 20282
29.08.Theralase Technologies Inc.: Theralase(R) Extends Warrants498Toronto, Ontario--(Newsfile Corp. - August 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
26.08.Theralase Technologies Inc.: Theralase(R) Releases 2Q2025 Financial Statements384Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering light, radiation...
► Artikel lesen
THERALASE Aktie jetzt für 0€ handeln
01.08.Theralase Technologies Inc: Theralase 3,363,134-share private placement2
28.07.Theralase Technologies Inc: Theralase Technologies closes $672,727 financing3
28.07.Theralase Technologies Inc.: Theralase(R) Closes Non-Brokered Private Placement213Toronto, Ontario--(Newsfile Corp. - July 28, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
28.06.Theralase Technologies Inc: Theralase to extend warrant expiry by three years1
27.06.Theralase Technologies Inc.: Theralase(R) Extends Warrants505Toronto, Ontario--(Newsfile Corp. - June 27, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
18.06.Theralase Technologies Inc: Theralase 2,885,000-share private placement1
17.06.Theralase Technologies Inc: Theralase closes $571,000 private placement4
17.06.Theralase Technologies Inc.: Theralase(R) Closes Non-Brokered Private Placement237Toronto, Ontario--(Newsfile Corp. - June 17, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
12.06.Theralase Technologies Inc: Theralase completes AGSM1
12.06.Theralase Technologies Inc.: Theralase Completes Annual General and Special Meeting252Toronto, Ontario--(Newsfile Corp. - June 12, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
09.06.Earnings Call Transkript: Theralase Technologies verfehlt EPS im Q1 2025, Aktie fällt4
05.06.Theralase Technologies Inc: Theralase to hold AGSM June 114
05.06.Theralase Technologies Inc.: Theralase Annual General Meeting420Toronto, Ontario--(Newsfile Corp. - June 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
30.05.Theralase Technologies Inc.: Theralase(R) 1Q2025 Financial Statements444Toronto, Ontario--(Newsfile Corp. - May 30, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
29.05.Theralase Technologies Inc.: Theralase to Present Groundbreaking Research at ASTRO 2025525Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
Weiter >>
52 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1